Remove 2030 Remove Biopharma Remove Strategic alliances
article thumbnail

The Future of Proteomics: Innovations, Challenges, and Industry Growth (2024-2030)

Frost & Sullivan

The global proteomics industry is poised for significant expansion between 2024 and 2030, driven by advances in research and pharmaceutical applications. Competitive Intensity Strategic alliances and proprietary technologies are becoming essential for market leadership. of Competitors 80, with revenue greater than $1.0